Author:
Duvnjak Marko,Blažević Nina,Jukić Lucija Virović
Reference39 articles.
1. Muñoz-Gámez JA, Salmerón J. Prevalence of hepatitis B and C in Spain – further data are needed. Revista Española de Enfermedades Digestivas. 2013;105:245-248
2. Meffre C, Le Strat Y, Delarocque-Astagneau E, et al. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: Social factors are important predictors after adjusting for known risk factors. Journal of Medical Virology. 2010;82:546-555
3. Van Damme P, Thyssen A, Van Loock F. Epidemiology of hepatitis C in Belgium: Present and future. Acta Gastro-Enterologica Belgica. 2002;65:78-79
4. Gańczak M, Szych Z. Rationale against preoperative screening for HIV in Polish hospitals: A prevalence study of anti-HIV in contrast to anti-hepatitis C virus and hepatitis B surface antigen. Infection Control and Hospital Epidemiology. 2009;30:1227-1229
5. Atanasova MV, Haydouchka IA, Zlatev SP, et al. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study. Minerva Gastroenterologica e Dietologica. 2004;50:89-96